Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,896.00p
   
  • Change Today:
      34.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 216,926
  • Market Cap: £4,206.97m
  • RiskGrade: 125

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.0% 0.0%
Div Cover 3.1 2.8
Op Mrgn 12.8% 22.1%
ROCE 15.8%  
Latest F'cast
P/E 10.8 12.0
PEG 0.5 n/a
Pr/Revenue 1.9 1.4
Pr/Book 2.4  
Latest F'cast
Revenue 14.2% -18.9%
PBT 20.6% 83.6%
EPS 23.2% -9.2%
DPS 28.6% -40.2%

HIK Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 2,207.00 491.00 150.40¢ 17.0 1.9 +9% 44.00¢ 1.7%
31-Dec-20 2,341.00 558.00 172.90¢ 18.7 1.2 +15% 50.00¢ 1.5%
31-Dec-21 2,553.00 544.00 194.80¢ 14.7 1.1 +13% 54.00¢ 1.9%
31-Dec-22 2,517.00 233.00 181.00¢ 11.0 n/a -7% 56.00¢ 2.8%
31-Dec-23 2,875.00 281.00 223.00¢ 10.3 0.4 +23% 72.00¢ 3.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

HIK Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 2,999.40 663.99 156.52p 11.9 n/a -9% 55.43p 0.0%
31-Dec-25 3,093.35 704.57 172.85p 10.8 1.0 +10% 58.82p 0.0%
31-Dec-26 3,240.73 745.36 188.59p 9.9 1.1 +9% 63.76p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

HIK Company Announcements

Notice of Results 15-Jul-2024 07:00 RNS
Total Voting Rights 01-Jul-2024 14:47 RNS
Director Declaration 27-Jun-2024 13:47 RNS

HIK ShareCast News

London close: Stocks mixed ahead of key UK infla... 17-Jun-2024 ShareCast
Hikma boosts injectables business with Xellia as... 17-Jun-2024 ShareCast
Citi hikes Hikma price target, cites 'healthy tr... 11-Jun-2024 ShareCast

HIK Top Newspaper Links

Hikma boosts injectables business with $300m deal 29-May-2014 Telegraph
MARKET REPORT: Shares jump as Hikma Pharmaceutic... 08-May-2014 Daily Mail
Hikma prepares return to Libya 26-Aug-2011 The Independent

Latest HIK Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

HIK Market Data

Currency UK Pounds
Share Price 1,896.00p
Change Today 34.00p
% Change 1.83 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 216,926
Shares Issued 221.89m
Market Cap £4,206.97m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.16% below the market average38.16% below the market average38.16% below the market average38.16% below the market average38.16% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
7.76% below the market average7.76% below the market average7.76% below the market average7.76% below the market average7.76% below the market average
61.54% above the sector average61.54% above the sector average61.54% above the sector average61.54% above the sector average61.54% above the sector average
Income
22.86% above the market average22.86% above the market average22.86% above the market average22.86% above the market average22.86% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
32.89% below the market average32.89% below the market average32.89% below the market average32.89% below the market average32.89% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 26-Jul-2024

Time Volume / Share Price
16:41 504 @ 1,885.24p
16:41 1,762 @ 1,885.24p
16:41 1,341 @ 1,885.24p
16:41 136 @ 1,885.24p
16:41 5,622 @ 1,885.24p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page